{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2006"],"condition":["Colorectal Cancer","Colorectal Neoplasms","This is a Phase II / III trial in Patients with Previously Untreated Metastatic Colorectal Cancer.","Metastatic colorectal cancer"],"disease":["This Is A Phase Ii / Iii Trial In Patients With Previously Untreated Metastatic Colorectal Cancer.","Metastatic Colorectal Cancer","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2033280"],"location":["Czechia","United States","Egypt","Thailand","Malta","Russia","Latvia","Vietnam","Austria","Poland","Slovakia","France","Hungary","Philippines","Ukraine","United Kingdom","India","Spain","Canada","Turkey","Belgium","Taiwan","Finland","Italy","South Africa","Israel","Australia","Germany"],"study_start_month":["8"],"keyword":["Metastatic Colorectal Cancer","Oxaliplatin","RECENTIN","Leucovorin","Cediranib","Fluorouracil","Bevacizumab"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX","description":"The purpose of this study is to see if Cediranib in combination with FOLFOX is effective in treating metastatic colorectal cancer and to see how it compares with Avastin (Bevacizumab) in combination with FOLFOX.","dates":{"creation":"2006-08-15"},"accession":"2033280","cross_references":{"ClinicalTrials___gov":["NCT00384176"],"EU Clinical Trials Register":["2005-003440-66"]}}